Literature DB >> 1932313

Familial aggregation of bladder cancer stratified by smoking status.

A A Kramer1, S Graham, W S Burnett, P Nasca.   

Abstract

To assess bladder cancer incidence in first-degree relatives of affected probands, bladder cancer patients and matched control probands provided general demographic and smoking information on their first-degree relatives. Bladder cancer incidence was established through information from the New York State Tumor Registry. The risk ratio for relatives of case probands versus relatives of control probands was 1.9; for relatives who smoked, the risk ratio was 2.1, while for nonsmoking relatives, the risk ratio was 1.8. Results from a proportional hazards regression analysis agreed with those above. These results indicate a familial component that is independent of smoking.

Entities:  

Mesh:

Year:  1991        PMID: 1932313     DOI: 10.1097/00001648-199103000-00010

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  11 in total

1.  Genetic susceptibility to bladder cancer risk and outcome.

Authors:  Jian Gu; Xifeng Wu
Journal:  Per Med       Date:  2011-05       Impact factor: 2.512

2.  Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case-Control Study.

Authors:  Christopher Martin; Claire L Leiser; Brock O'Neil; Sumati Gupta; William T Lowrance; Wendy Kohlmann; Samantha Greenberg; Piyush Pathak; Ken R Smith; Heidi A Hanson
Journal:  J Natl Cancer Inst       Date:  2018-05-01       Impact factor: 13.506

Review 3.  Familial and genetic risk of transitional cell carcinoma of the urinary tract.

Authors:  Christine M Mueller; Neil Caporaso; Mark H Greene
Journal:  Urol Oncol       Date:  2008-06-18       Impact factor: 3.498

Review 4.  Superficial bladder cancer.

Authors:  R R Hall
Journal:  BMJ       Date:  1994-04-02

5.  Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk.

Authors:  Meng Chen; Adrian Cassidy; Jian Gu; George L Delclos; Fan Zhen; Hushan Yang; Michelle A T Hildebrandt; Jie Lin; Yuanqing Ye; Robert M Chamberlain; Colin P Dinney; Xifeng Wu
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

6.  Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.

Authors:  Maria I Carlo; Vignesh Ravichandran; Preethi Srinavasan; Chaitanya Bandlamudi; Yelena Kemel; Ozge Ceyhan-Birsoy; Semanti Mukherjee; Diana Mandelker; Joshua Chaim; Andrea Knezevic; Satshil Rana; Zarina Fnu; Kelsey Breen; Angela G Arnold; Aliya Khurram; Kaitlyn Tkachuk; Catharine K Cipolla; Ashley Regazzi; A Ari Hakimi; Hikmat Al-Ahmadie; Guido Dalbagni; Karen A Cadoo; Michael F Walsh; Min-Yuen Teo; Samuel A Funt; Jonathan A Coleman; Bernard H Bochner; Gopa Iyer; David B Solit; Zsofia K Stadler; Liying Zhang; Jonathan E Rosenberg; Barry S Taylor; Mark E Robson; Michael F Berger; Joseph Vijai; Dean F Bajorin; Kenneth Offit
Journal:  J Clin Oncol       Date:  2019-12-03       Impact factor: 44.544

Review 7.  The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development.

Authors:  Paulina Wigner; Radosław Grębowski; Michał Bijak; Joanna Saluk-Bijak; Janusz Szemraj
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

Review 8.  Systematic review of the relationship between family history and lung cancer risk.

Authors:  A Matakidou; T Eisen; R S Houlston
Journal:  Br J Cancer       Date:  2005-10-03       Impact factor: 7.640

9.  Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer development.

Authors:  Meng Chen; Nathaniel Rothman; Yuanqing Ye; Jian Gu; Paul A Scheet; Maosheng Huang; David W Chang; Colin P Dinney; Debra T Silverman; Jonine D Figueroa; Stephen J Chanock; Xifeng Wu
Journal:  Genes Cancer       Date:  2016-07

Review 10.  Epidemiology of urinary bladder cancer: from tumor development to patient's death.

Authors:  Cristiane Murta-Nascimento; Bernd J Schmitz-Dräger; Maurice P Zeegers; Gunnar Steineck; Manolis Kogevinas; Francisco X Real; Núria Malats
Journal:  World J Urol       Date:  2007-06       Impact factor: 3.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.